Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Global proteomics and metabolic data for CD36-mediated endocytosis of proteolysis-targeting chimeras

ABSTRACT: Global proteomics and metabolic data for CD36-mediated endocytosis of proteolysis-targeting chimeras are deposited here.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Hong-yu Li

PROVIDER: PXD062797 | JPOST Repository | Thu Apr 10 00:00:00 BST 2025

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	Data_S1_Global_proteomic_analysis_raw_data.xlsx	Xlsx
	Global_proteomics_033949_QinZ_20241126_02_DIA.sne	Other
	Global_proteomics_QinZ_20241126_02_DIA_raw.zip	Other
	Table_S4_Metabolomic_assay_raw_data.xlsx	Xlsx

Items per page:

1 - 4 of 4

Similar Datasets

Global proteomics and metabolic data for CD36-mediated endocytosis of proteolysis-targeting chimeras

Project description:Global proteomics and metabolic data for CD36-mediated endocytosis of proteolysis-targeting chimeras has been deposited here.

2025-04-09 | PXD062747 | JPOST Repository

YY1-mediated targeting of MSL/MOF

Project description:YY1-mediated targeting of MSL/MOF

| PRJNA1012719 | ENA

Targeting CD36-PPARβ signaling-mediated metabolic adaptation in intratumoral Tregs primes tumors for PD-1 blockade

Project description:Targeting CD36-PPARβ signaling-mediated metabolic adaptation in intratumoral Tregs primes tumors for PD-1 blockade

| PRJNA579319 | ENA

Targeting Unique Metabolic Properties of Breast Tumor Initiating Cells

Project description:Bulk cancer cell populations are known to display distinct metabolic properties compared to their normal counterparts. However, relatively little is known about heterogeneity of metabolic properties within tumors. In this study we show that, analogous to some normal stem cells, breast tumor initiating cells (TICs, also called cancer stem cells) have distinct metabolic properties compared to non-tumorigenic cancer cells (NTCs). Transcriptome profiling using RNA-Seq revealed TICs under-express genes involved in mitochondrial oxidative phosphorylation and although TICs are relatively quiescent, they preferentially perform glycolysis over oxidative phosphorylation compared to NTCs. TICs contain fewer mitochondria and display lower expression and activity of pyruvate dehydrogenase (Pdh), a key regulator of oxidative phosphorylation. Metabolic reprogramming of TICs by pharmacologic activation of Pdh preferentially eliminates TICs in vitro and in vivo. Our findings reveal unique metabolic properties of TICs and indicate that metabolic reprogramming represents a promising strategy for targeting these cells. Examination transcriptome profiles for breast tumor initiating cells (TICs) and non-tumorigenic cells (NTCs)

2014-07-31 | E-GEOD-41286 | biostudies-arrayexpress

Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma

Project description:Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma

| PRJNA807285 | ENA

Targeting Pancreatic Cancer Metabolic Dependencies through Glutamine Antagonism

Project description:Targeting Pancreatic Cancer Metabolic Dependencies through Glutamine Antagonism

| PRJNA989511 | ENA

MAD2-dependent insulin receptor endocytosis regulates metabolic homeostasis

Project description:MAD2-dependent insulin receptor endocytosis regulates metabolic homeostasis

| PRJNA1004260 | ENA

Targeting cancer through simultaneous inhibition of key metabolic enzymes

Project description:Targeting cancer through simultaneous inhibition of key metabolic enzymes

| PRJNA1205711 | ENA

Dual targeting PPARα and NPC1L1 metabolic vulnerabilities blocks tumorigenesis

Project description:Dual targeting PPARα and NPC1L1 metabolic vulnerabilities blocks tumorigenesis

| PRJNA1205682 | ENA

Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple Myeloma

Project description:Targeting DNA2 is synthetically lethal in myeloma cells that undergo metabolic adaptation and rely on oxidative phosphorylation to maintain survival after DNA damage activation.

2023-11-27 | GSE196766 | GEO